These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 4789533)

  • 1. [Antifibrous action of polyvinyl-pyridine-N-oxides in experimental silicosis].
    Bezrodnykh AA; Kasparov AA; Mazurov VI; Razvodovskiĭ EF; Kochetkova TA
    Gig Tr Prof Zabol; 1973 Dec; 17(12):20-4. PubMed ID: 4789533
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prophylactic action of polyvinylpyridine-N-oxide of different molecular weights on experimental silicosis].
    Bogdanskaia NI; Tolgskaia MS
    Gig Sanit; 1973 Apr; 38(4):102-4. PubMed ID: 4731236
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of experimental silicosis with polyvinyl-pyridine-N-oxide].
    Bogdanskaia NI
    Gig Tr Prof Zabol; 1973 May; 17(5):22-5. PubMed ID: 4771393
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hydroxyproline content in the peptide makeup of the lung tissue of animals with experimental silicosis].
    Rodkina BS
    Ukr Biokhim Zh; 1974; 46(3):393-7. PubMed ID: 4836947
    [No Abstract]   [Full Text] [Related]  

  • 5. [Regression of experimental silicotic granuloma under the influence of polyvinylpyridin-N-oxide].
    Grundmann E; Schlipköter HW
    Verh Dtsch Ges Pathol; 1969; 53():367-70. PubMed ID: 4191095
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical studies on the elimination of hydroxyproline during treatment of silicosis in man with polyvinyl-pyridine-N-oxide (author's transl)].
    Schlipköter H; Grünspan M; Dehnen W; Mallner B
    Infection; 1974; 2(1):25-8. PubMed ID: 4598261
    [No Abstract]   [Full Text] [Related]  

  • 7. [Possible paths for influencing the mechanism of experimental silicosis].
    Shnaĭdman IM; Raĭkhlin NT
    Biull Eksp Biol Med; 1973 Jun; 75(6):27-30. PubMed ID: 4149770
    [No Abstract]   [Full Text] [Related]  

  • 8. [Behavior of the human liver during silicosis therapy using polyvinylpyridine-N-oxide (PVNO)].
    Haas P; Huber W
    Beitr Silikoseforsch Pneumokoniose; 1971; 23(3):91-100. PubMed ID: 5171411
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antisilicotic properties of polyvinylpyridine-N-oxide with a different molecular weight].
    Dubovik BV; Shadurskiĭ KS; Etlis VS; Lushnikova GA; Shevchuk AS
    Farmakol Toksikol; 1971; 34(3):352-7. PubMed ID: 5568700
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of serum polyvinylpyridine-N-oxide after intravenous administration in silicosis patients].
    Grünspan M; Antweiler H; Marcic I
    Beitr Silikoseforsch Pneumokoniose; 1971; 23(3):101-13. PubMed ID: 5171408
    [No Abstract]   [Full Text] [Related]  

  • 11. [Occupational lung diseases].
    Woitowitz HJ
    MMW Munch Med Wochenschr; 1974 Jan; 116(4):131-6. PubMed ID: 4150262
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental silicosis caused by the dust from extra-pure crystalline silicon and the effect of polyvinylpyridine N-oxide on its course].
    Golodnikov IuN
    Gig Tr Prof Zabol; 1978 Dec; (12):31-6. PubMed ID: 720881
    [No Abstract]   [Full Text] [Related]  

  • 13. [Change in the phospholipid status in experimental silicosis in rats and in exposure to polymeric preparations].
    Kupina LM
    Gig Tr Prof Zabol; 1978 Sep; (9):16-20. PubMed ID: 689453
    [No Abstract]   [Full Text] [Related]  

  • 14. [Animal experimental fundamentals in the medicinal prevention of silicosis using polyvinylpyridine-N-oxide (P204)].
    Pott F; Schlipköter HW; Brockhaus A
    Dtsch Med Wochenschr; 1968 Dec; 93(51):2479-82. PubMed ID: 5724499
    [No Abstract]   [Full Text] [Related]  

  • 15. [Influence of polyvinylpyridine-N-oxide on matured experimental silicosis in the liver-spleen test].
    Heeren E; Eger W; Einbrodt HJ
    Beitr Silikoseforsch Pneumokoniose; 1971; 23(3):137-50. PubMed ID: 5171409
    [No Abstract]   [Full Text] [Related]  

  • 16. [Current aspects of treatment of silicosis].
    Sidorova NV
    Sov Med; 1974 Aug; 0(8):39-43. PubMed ID: 4610803
    [No Abstract]   [Full Text] [Related]  

  • 17. [Toxicological and pharmacological properties of polyvinyl pyridine-N-oxide with different molecular weights].
    Shadurskiĭ KS; Dubovik BV; Il'iuchenok TIu; Shevchuk AS; Lushnikova GA
    Farmakol Toksikol; 1971; 34(4):485-9. PubMed ID: 5160795
    [No Abstract]   [Full Text] [Related]  

  • 18. [Action of polyvinylpyridine N-oxide on individual lung tissue indices in experimental silicosis].
    Mukhina ST; Veretinskaia AG
    Gig Tr Prof Zabol; 1974 Oct; (10):33-5. PubMed ID: 4465165
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of polyvinyl-pyridine-N-oxide on lung histamine.
    Matin MA; Zaidi SH
    Arch Int Pharmacodyn Ther; 1970 Nov; 188(1):163-7. PubMed ID: 4098619
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of polyvinylpyridine N-oxide on pulmonary tissue scleroproteins in experimental silicosis].
    Gel'fon IA
    Gig Tr Prof Zabol; 1978 Sep; (9):54. PubMed ID: 689462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.